← Open Payments lookup

MARY RENFROW: Open Payments

NPI 1801372800 · TOWSON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$338 in 16 payments from 8 companies in 2025. Trend: 2023 $313 · 2024 $394 · 2025 $338

Food & beverage: $338
CompanyPaymentsAmount
ABBVIE INC.5$80
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$68
Ardelyx, Inc.2$55
Takeda Pharmaceuticals U.S.A., Inc.2$47
GENZYME CORPORATION1$26
Aimmune Therapeutics, Inc.1$23
Lilly USA, LLC1$22
Janssen Biotech, Inc.1$17

Products named: XIFAXAN, SKYRIZI, IBSRELA, DUPIXENT, GATTEX, EOHILIA, ZENPEP, OMVOH.

Industry payments across MD — which companies pay providers there.